Mutational analysis of patients with the diagnosis of choroideremia
- PMID: 12203991
- DOI: 10.1002/humu.10114
Mutational analysis of patients with the diagnosis of choroideremia
Abstract
All reported mutations in the choroideremia (CHM) gene result in the truncation or complete absence of Rab escort protein 1 (REP1). Molecular analysis was carried out on 57 families diagnosed with CHM. Confirmation of the clinical diagnosis is important as end-stage CHM may be clinically similar to the end stages of other retinal degenerative diseases such as RP. The primary means of confirming the diagnosis of CHM is to sequence all 15 exons. An alternative method involves detection of the REP1 protein, as described in MacDonald et al. [1998]. A monoclonal antibody to REP1 does not detect truncated REP1 by immunoblot analysis, presumably due to instability and subsequent degradation of the truncated protein. This analysis provides relatively fast confirmation of the diagnosis, however, protein samples are not always available and are susceptible to degradation, affecting the accurate interpretation of results. CHM gene mutations were found in 54 of 57 families studied. The majority of mutations (>42%) were transitions and transversions. Complete deletions of the CHM gene and deletion/insertion mutations each accounted for almost 4% of the total, while over 9% had large intragenic and other partial deletions. Almost 28% of the mutations were deletions of fewer than 5 base pairs (bp) and almost 13% were splice site mutations. Despite the fact that mutations are found throughout the gene with no common mutation for the disorder, identical mutations have been characterized in unrelated individuals. The majority of these mutations are C to T transitions, changing an arginine residue (CGA) to a stop codon (TGA). Four of the five CGA codons in the CHM gene are sites of recurring mutations.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
A practical diagnostic test for choroideremia.Ophthalmology. 1998 Sep;105(9):1637-40. doi: 10.1016/S0161-6420(98)99031-5. Ophthalmology. 1998. PMID: 9754170
-
Novel types of mutation in the choroideremia ( CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon.Hum Genet. 2003 Aug;113(3):268-75. doi: 10.1007/s00439-003-0970-0. Epub 2003 Jun 25. Hum Genet. 2003. PMID: 12827496
-
Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase.Hum Mutat. 2011 Dec;32(12):1460-9. doi: 10.1002/humu.21591. Epub 2011 Oct 11. Hum Mutat. 2011. PMID: 21905166
-
Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene.Hum Mutat. 1997;9(2):110-7. doi: 10.1002/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.0.CO;2-D. Hum Mutat. 1997. PMID: 9067750 Review.
-
Rab escort protein 1 (REP1) in intracellular traffic: a functional and pathophysiological overview.Ophthalmic Genet. 2004 Jun;25(2):101-10. doi: 10.1080/13816810490514333. Ophthalmic Genet. 2004. PMID: 15370541 Review.
Cited by
-
Pathogenic mechanisms and the prospect of gene therapy for choroideremia.Expert Opin Orphan Drugs. 2015 Jul 1;3(7):787-798. doi: 10.1517/21678707.2015.1046434. Expert Opin Orphan Drugs. 2015. PMID: 26251765 Free PMC article.
-
Retinal dystrophies, genomic applications in diagnosis and prospects for therapy.Transl Pediatr. 2015 Apr;4(2):139-63. doi: 10.3978/j.issn.2224-4336.2015.04.03. Transl Pediatr. 2015. PMID: 26835369 Free PMC article. Review.
-
Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2099-2111. doi: 10.1007/s00417-017-3751-5. Epub 2017 Jul 27. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28752371
-
CHOROIDEREMIA ASSOCIATED WITH A NOVEL SYNONYMOUS MUTATION IN GENE ENCODING REP-1.Retin Cases Brief Rep. 2018 Fall;12 Suppl 1(Suppl 1):S67-S71. doi: 10.1097/ICB.0000000000000647. Retin Cases Brief Rep. 2018. PMID: 29045269 Free PMC article.
-
Choroideremia: new findings from ocular pathology and review of recent literature.Surv Ophthalmol. 2009 May-Jun;54(3):401-7. doi: 10.1016/j.survophthal.2009.02.008. Surv Ophthalmol. 2009. PMID: 19422966 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials